$ICUI
ICU MEDICAL INC/DE Stock $icui

$icui Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000088398424000005 Filed on February 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$566.7M	$587.9M	$2.259B
YoY Change	-0.35%	1.7%	-0.92%
Cost Of Revenue	$381.4M	$416.3M	$1.519B
YoY Change	1.28%	3.28%	-3.98%
Gross Profit	$185.2M	$171.6M	$739.9M
YoY Change	-3.54%	-1.92%	6.04%
Gross Profit Margin	32.69%	29.19%	32.75%
Selling, General & Admin	$157.7M	$154.3M	$606.7M
YoY Change	3.33%	8.13%	-0.27%
% of Gross Profit	85.11%	89.95%	82.0%
Research & Development	$21.84M	$22.41M	$85.34M
YoY Change	10.53%	-4.41%	-8.22%
% of Gross Profit	11.79%	13.06%	11.53%
Depreciation & Amortization	$55.53M	$57.16M	$228.8M
YoY Change	-0.39%	0.61%	-2.71%
% of Gross Profit	29.97%	33.31%	30.92%
Operating Expenses	$195.9M	$173.0M	$717.0M
YoY Change	7.26%	4.53%	-3.19%
Operating Profit	-$10.66M	-$1.452M	$22.83M
YoY Change	-213.41%	-115.44%	-153.21%
Interest Expense	$23.77M	-$24.68M	$102.7M
YoY Change	5.58%	15.93%	45.08%
% of Operating Profit			450.06%
Other Income/Expense, Net	-$2.341M	-$639.0K	-$5.905M
YoY Change	770.26%	-302.22%	14.97%
Pretax Income	-$36.77M	-$36.68M	-$137.0M
YoY Change	174.61%	71.03%	0.98%
Income Tax	$2.703M	-$19.53M	-$48.64M
% Of Pretax Income
Net Earnings	-$39.47M	-$17.15M	-$29.66M
YoY Change	302.27%	10.37%	-60.08%
Net Earnings / Revenue	-6.97%	-2.92%	-1.31%
Basic Earnings Per Share	-$1.63		-$1.23
Diluted Earnings Per Share	-$1.63	-$0.71	-$1.23
COMMON SHARES
Basic Shares Outstanding	24.14M shares	24.14M shares	24.09M shares
Diluted Shares Outstanding	24.22M shares		24.09M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$251.4M	$254.7M	$254.7M
YoY Change	12.15%	19.58%	19.58%
Cash & Equivalents	$251.4M	$254.2M	$254.2M
Short-Term Investments	$0.00	$501.0K	$501.0K
Other Short-Term Assets	$4.500M	$3.667M	$92.88M
YoY Change	27.15%	3.82%	-7.97%
Inventory	$693.0M	$709.4M	$709.4M
Prepaid Expenses
Receivables	$145.2M	$161.6M	$161.6M
Other Receivables	$2.995M	$2.748M	$2.748M
Total Short-Term Assets	$1.188B	$1.221B	$1.221B
YoY Change	-2.09%	-1.13%	-1.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$602.6M	$612.9M	$685.5M
YoY Change	-3.44%	-3.65%	-3.93%
Goodwill	$1.459B	$1.472B
YoY Change	-0.23%	1.6%
Intangibles	$836.9M	$870.6M
YoY Change	-12.61%	-11.41%
Long-Term Investments	$3.104M	$3.120M	$3.120M
YoY Change	-1.96%	-1.83%	-15.54%
Other Assets	$96.65M	$94.02M	$125.5M
YoY Change	-5.14%	-10.85%	-4.32%
Total Long-Term Assets	$3.101B	$3.157B	$3.157B
YoY Change	-4.82%	-3.76%	-3.76%
TOTAL ASSETS
Total Short-Term Assets	$1.188B	$1.221B	$1.221B
Total Long-Term Assets	$3.101B	$3.157B	$3.157B
Total Assets	$4.288B	$4.378B	$4.378B
YoY Change	-4.08%	-3.04%	-3.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$152.5M	$150.0M	$150.0M
YoY Change	-18.21%	-30.51%	-30.51%
Accrued Expenses	$247.9M	$268.2M	$235.7M
YoY Change	5.41%	10.48%	11.65%
Deferred Revenue		$31.64M
YoY Change		2.6%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$51.00M	$51.00M	$51.86M
YoY Change	45.45%	71.79%	70.01%
Total Short-Term Liabilities	$455.4M	$481.8M	$481.8M
YoY Change	-1.47%	-2.57%	-2.57%
LONG-TERM LIABILITIES
Long-Term Debt	$1.566B	$1.578B	$1.580B
YoY Change	-2.85%	-2.83%	-2.82%
Other Long-Term Liabilities	$102.6M	$137.6M	$137.6M
YoY Change	-10.18%	-23.4%	-23.4%
Total Long-Term Liabilities	$1.669B	$1.578B	$1.717B
YoY Change	-3.33%	-2.83%	-4.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$455.4M	$481.8M	$481.8M
Total Long-Term Liabilities	$1.669B	$1.578B	$1.717B
Total Liabilities	$2.124B	$2.060B	$2.255B
YoY Change	-2.94%	-2.77%	-7.04%
SHAREHOLDERS EQUITY
Retained Earnings	$768.4M	$807.8M
YoY Change	-7.17%	-3.54%
Common Stock	$1.374B	$1.369B
YoY Change	2.34%	2.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$4.692M	$262.0K
YoY Change	-41.39%	7.82%
Treasury Stock Shares
Shareholders Equity	$2.068B	$2.123B	$2.123B
YoY Change
Total Liabilities & Shareholders Equity	$4.288B	$4.378B	$4.378B
YoY Change	-4.08%	-3.04%	-3.04%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$39.47M	-$17.15M	-$29.66M
YoY Change	302.27%	10.37%	-60.08%
Depreciation, Depletion And Amortization	$55.53M	$57.16M	$228.8M
YoY Change	-0.39%	0.61%	-2.71%
Cash From Operating Activities	$45.79M	$91.27M	$166.2M
YoY Change	11.02%	-5434.25%	-367.51%
INVESTING ACTIVITIES
Capital Expenditures	$15.92M	$31.97M	$83.89M
YoY Change	12.04%	32.92%	-7.11%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$1.007M	$1.322M	$5.723M
YoY Change	-35.2%	2260.71%	-100.32%
Cash From Investing Activities	-$17.86M	-$30.65M	-$87.95M
YoY Change	17.64%	27.72%	-95.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$9.350M
YoY Change			-14.09%
Debt Paid & Issued, Net	$12.75M		$29.69M
YoY Change	72.88%		32.68%
Cash From Financing Activities	-$26.85M	-7.849M	-$35.98M
YoY Change	69.51%	-24.42%	-102.2%
NET CHANGE
Cash From Operating Activities	$45.79M	91.27M	$166.2M
Cash From Investing Activities	-$17.86M	-30.65M	-$87.95M
Cash From Financing Activities	-$26.85M	-7.849M	-$35.98M
Net Change In Cash	-$2.799M	52.77M	$45.44M
YoY Change	-123.01%	-246.2%	-113.21%
FREE CASH FLOW
Cash From Operating Activities	$45.79M	$91.27M	$166.2M
Capital Expenditures	$15.92M	$31.97M	$83.89M
Free Cash Flow	$29.88M	$59.30M	$82.31M
YoY Change	10.49%	-330.15%	-153.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.23
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.23
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.11
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23868000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21206000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21781000	shares
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	18000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1909468000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-90687000	usd
CY2023	icui	Proceeds From Issuance Of Long Term Debt Net Of Lender Debt Issuance Costs ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts	0	usd
CY2022	icui	Proceeds From Issuance Of Long Term Debt Net Of Lender Debt Issuance Costs ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts	1664362000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	29688000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000883984
CY2023	dei	Entity Registrant Name EntityRegistrantName	ICU MEDICAL INC/DE
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	us-gaap	Gain On Business Interruption Insurance Recovery Statement Of Income Or Comprehensive Income Extensible Enumeration GainOnBusinessInterruptionInsuranceRecoveryStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#NonoperatingIncomeExpense
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilities
CY2023	us-gaap	Derivative Instrument Gain Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#InterestIncomeExpenseNet
CY2023	us-gaap	Fair Value Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List FairValueLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Security12b Title Security12bTitle	Common stock, par value $0.10 per share
CY2023	dei	Trading Symbol TradingSymbol	ICUI
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	3601073250	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24142564	shares
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2023	dei	Auditor Location AuditorLocation	Costa Mesa, California
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	254222000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208784000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	501000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	4224000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	254723000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	213008000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11064000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8530000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	161566000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	221719000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	709360000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	696009000	usd
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes	21983000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	15528000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73640000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	88932000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1221272000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1235196000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	612909000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	636113000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	69909000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	74864000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	516000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1472446000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1449258000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	870588000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	982766000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	37295000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	31466000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	94020000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	105462000	usd
CY2023Q4	us-gaap	Assets Assets	4378439000	usd
CY2022Q4	us-gaap	Assets Assets	4515641000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	150030000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	215902000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	268215000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	242769000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	51000000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	29688000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	7714000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6200000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	4879000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	481838000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	494559000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3991000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	25572000	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	1577770000	usd
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	1623675000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	100497000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	114104000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	55873000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	126007000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	35060000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	41796000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	usd
CY2022Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24144000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23995000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24141000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23993000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2414000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2399000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1366493000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1331249000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2428	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1633	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	262000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	243000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	807846000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	837501000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-53081000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-80978000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2123410000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2089928000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4378439000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4515641000	usd
CY2023	us-gaap	Revenues Revenues	2259126000	usd
CY2022	us-gaap	Revenues Revenues	2279997000	usd
CY2021	us-gaap	Revenues Revenues	1316308000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1519253000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1582236000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	824818000	usd
CY2023	us-gaap	Gross Profit GrossProfit	739873000	usd
CY2022	us-gaap	Gross Profit GrossProfit	697761000	usd
CY2021	us-gaap	Gross Profit GrossProfit	491490000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	606693000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	608345000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	302583000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	85344000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	92984000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47498000	usd
CY2023	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	41258000	usd
CY2022	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	71421000	usd
CY2021	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	18037000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-16247000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-32091000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-135995000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	85388000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1502265000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	icui	Contractsettlements Contractsettlements	0	usd
CY2022	icui	Contractsettlements Contractsettlements	0	usd
CY2021	icui	Contractsettlements Contractsettlements	127000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	717048000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	740659000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	368245000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	22825000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-42898000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	123245000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-95219000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-66375000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1982000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5905000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5136000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2041000	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-78299000	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-114409000	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	123186000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-48644000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-40123000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20051000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-29655000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-74286000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	103135000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.11
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.86
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.74
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-29655000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-74286000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	103135000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-18895000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	46189000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-103928000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-14664000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-603000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1203000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	62000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	27897000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-61709000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-17747000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1758000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9372000	usd
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	8335000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27341000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-17747000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	103135000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1616031000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8785000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	10883000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	575975000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	36025000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-61719000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-74286000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2089928000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4022000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9350000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	40563000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	27902000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-29655000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2123410000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-74286000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	103135000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	228774000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	235151000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	89698000	usd
CY2023	icui	Amortization Of Inventory Step Up AmortizationOfInventoryStepUp	0	usd
CY2022	icui	Amortization Of Inventory Step Up AmortizationOfInventoryStepUp	26519000	usd
CY2021	icui	Amortization Of Inventory Step Up AmortizationOfInventoryStepUp	0	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	21910000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	23651000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	9594000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	838000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1036000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	345000	usd
CY2023	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	21582000	usd
CY2022	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	4902000	usd
CY2021	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	831000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	40563000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	36025000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	27341000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2109000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2010000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1652000	usd
CY2023	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	17000	usd
CY2022	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	264000	usd
CY2021	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	655000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6814000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6972000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	240000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-16247000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-32091000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	0	usd
CY2022	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	0	usd
CY2021	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	3380000	usd
CY2023	icui	Sparepartsusage Sparepartsusage	17050000	usd
CY2022	icui	Sparepartsusage Sparepartsusage	11924000	usd
CY2021	icui	Sparepartsusage Sparepartsusage	13046000	usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	8049000	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-477000	usd
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	2582000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-48635000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19151000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-13755000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6079000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	201095000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-20815000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-11672000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-22903000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7973000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	24695000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	21290000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	21038000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-68301000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	37472000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2347000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-14479000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-55834000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6259000	usd
CY2023	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-82356000	usd
CY2022	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-66734000	usd
CY2021	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	874000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	166201000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-62129000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	267538000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83893000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	90311000	usd
CY2023	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	1501000	usd
CY2022	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	989000	usd
CY2021	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	218000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	12627000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1844164000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	14452000	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3250000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3397000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	10034000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4222000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	36433000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-87947000	usd
CY2021	icui	Proceeds From Issuance Of Long Term Debt Net Of Lender Debt Issuance Costs ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts	0	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	22375000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2177000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4022000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8785000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9372000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	963000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	680000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	607000	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	17300000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9350000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10883000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8335000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35979000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1637032000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-16870000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3163000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9478000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3251000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	45438000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-344043000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	156730000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208784000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	552827000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	396097000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	254222000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208784000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	552827000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	35809000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	27504000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	19562000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	95913000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	63713000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	858000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6570000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4854000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9338000	usd
CY2021	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	0	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Use Of Estimates UseOfEstimates	Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	296037000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	286964000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	58906000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	73795000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	354417000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	335250000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	709360000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	696009000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1236797000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1162557000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	623888000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	526444000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	612909000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	636113000	usd
CY2023	us-gaap	Depreciation Depreciation	96700000	usd
CY2022	us-gaap	Depreciation Depreciation	95800000	usd
CY2021	us-gaap	Depreciation Depreciation	65900000	usd
CY2020Q4	us-gaap	Goodwill Goodwill	33001000	usd
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	10626000	usd
CY2021	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-188000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	43439000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1469880000	usd
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-7128000	usd
CY2022	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-650000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-56283000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1449258000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	23188000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1472446000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1218889000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	386621000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	832268000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1257209000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	386621000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	870588000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1202911000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	251951000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	950960000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1234717000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	251951000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	982766000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	132100000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	139400000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23800000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	132623000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	125149000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	124396000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	114308000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	113710000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	222082000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	832268000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	501000	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	501000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	501000	usd
CY2023	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	501000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	4224000	usd
CY2022	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	4224000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4740000	usd
CY2022	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4740000	usd
CY2021Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	3300000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3120000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3178000	usd
CY2023Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	2900000	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	2000000	usd
CY2022Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	2200000	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	2300000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-5900000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-5800000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-1000000	usd
CY2023	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	19200000	usd
CY2022	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	14600000	usd
CY2021	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	11000000	usd
CY2023	us-gaap	Interest Expense InterestExpense	102727000	usd
CY2022	us-gaap	Interest Expense InterestExpense	70805000	usd
CY2021	us-gaap	Interest Expense InterestExpense	858000	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	7508000	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	4430000	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	2840000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-95219000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-66375000	usd
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1982000	usd
CY2023	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	5918000	usd
CY2022	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	5780000	usd
CY2021	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	1017000	usd
CY2023	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-153000	usd
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-2554000	usd
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-1651000	usd
CY2023	icui	Miscellaneous Income Net MiscellaneousIncomeNet	166000	usd
CY2022	icui	Miscellaneous Income Net MiscellaneousIncomeNet	3198000	usd
CY2021	icui	Miscellaneous Income Net MiscellaneousIncomeNet	627000	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-5905000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-5136000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2041000	usd
CY2023	us-gaap	Gain Loss On Sale Of Accounts Receivable GainLossOnSaleOfAccountsReceivable	3700000	usd
CY2023Q4	icui	Total Insurance Proceeds TotalInsuranceProceeds	3100000	usd
CY2023	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	2600000	usd
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12354	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-29655000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-74286000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	103135000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24091000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23868000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21206000	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	575000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24091000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23868000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21781000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.23
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.11
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.86
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.23
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.11
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.74
CY2023	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	8300000	usd
CY2022	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	37600000	usd
CY2022Q4	icui	Related Party Open Payable RelatedPartyOpenPayable	5100000	usd
CY2023	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	41300000	usd
CY2022	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	71400000	usd
CY2021	icui	Restructuringandstrategictransactionexpense Restructuringandstrategictransactionexpense	18000000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	5700000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	9700000	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	-1800000	usd
CY2021	icui	Restructuring Adjustments Severance And Facility RestructuringAdjustmentsSeveranceAndFacility	2000000	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	-1800000	usd
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	664000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Restructuring Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities	7536000	usd
CY2022	us-gaap	Restructuring Costs RestructuringCosts	9725000	usd
CY2022	us-gaap	Payments For Restructuring PaymentsForRestructuring	11351000	usd
CY2022	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	613000	usd
CY2022	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	38000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	5923000	usd
CY2023	us-gaap	Restructuring Costs RestructuringCosts	6710000	usd
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	7886000	usd
CY2023	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	1019000	usd
CY2023	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	160000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	3568000	usd
CY2023	icui	Strategic Transactionand Integration StrategicTransactionandIntegration	35600000	usd
CY2022	icui	Strategic Transactionand Integration StrategicTransactionandIntegration	61700000	usd
CY2021	icui	Strategic Transactionand Integration StrategicTransactionandIntegration	19800000	usd
CY2023	us-gaap	Revenues Revenues	2259126000	usd
CY2023	icui	Percentageofrevenue Percentageofrevenue	1
CY2022	us-gaap	Revenues Revenues	2279997000	usd
CY2022	icui	Percentageofrevenue Percentageofrevenue	1
CY2021	us-gaap	Revenues Revenues	1316308000	usd
CY2021	icui	Percentageofrevenue Percentageofrevenue	1
CY2023	us-gaap	Revenues Revenues	2259126000	usd
CY2022	us-gaap	Revenues Revenues	2279997000	usd
CY2021	us-gaap	Revenues Revenues	1316308000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7461000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	45866000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	42177000	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	29800000	usd
CY2023	icui	Optiontoextendinyears Optiontoextendinyears	P5Y
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	24024000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	22038000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	11251000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	125000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	112000	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	122000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1035000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	712000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	648000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	29000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	14000	usd
CY2023	us-gaap	Lease Cost LeaseCost	25213000	usd
CY2022	us-gaap	Lease Cost LeaseCost	22869000	usd
CY2021	us-gaap	Lease Cost LeaseCost	12035000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	24604000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	25225000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	11256000	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	125000	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	112000	usd
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	122000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	15873000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5994000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2589000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1028000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	715000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	558000	usd
CY2023Q4	icui	Business Combination Recognized Identifiable Asset Acquired And Liability Assumed BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed	55200000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	69909000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	74864000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20161000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18169000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	52972000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	60916000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	73133000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	79085000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y7M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0431
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0434
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2707000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2598000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	860000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	816000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1954000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1855000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2814000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2671000	usd
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y1M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0493
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0423
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22291000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	977000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	977000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	16409000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	763000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	14095000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	639000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	10150000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	291000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5735000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	189000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	13041000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	236000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	81721000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3095000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	8588000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	281000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	73133000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2814000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	1733000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	3637000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	5092000	usd
CY2023	icui	Modified Prsu Incremental Expense ModifiedPRSUIncrementalExpense	2100000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	40563000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	36025000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	27341000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5379000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4636000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6391000	usd
CY2023	icui	Indirect Tax Benefit From Stock Options IndirectTaxBenefitFromStockOptions	0	usd
CY2022	icui	Indirect Tax Benefit From Stock Options IndirectTaxBenefitFromStockOptions	749000	usd
CY2021	icui	Indirect Tax Benefit From Stock Options IndirectTaxBenefitFromStockOptions	285000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	43100000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y10M24D
CY2023Q4	us-gaap	Share Price SharePrice	99.74
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8441000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	17340000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	27534000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4022000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8785000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9372000	usd
CY2023Q4	icui	Espp Original Issuance ESPPOriginalIssuance	750000	shares
CY2023Q4	icui	Espp Annual Issuance Increase Limit ESPPAnnualIssuanceIncreaseLimit	300000	shares
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	172600000	usd
CY2023	us-gaap	Derivative Instruments Gain Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	40834000	usd
CY2022	us-gaap	Derivative Instruments Gain Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	18419000	usd
CY2021	us-gaap	Derivative Instruments Gain Reclassified From Accumulated Oci Into Income Effective Portion DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion	3444000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	15988000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	72374000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-530000	usd
CY2023Q4	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	4200000	usd
CY2023Q4	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	-23900000	usd
CY2021Q4	icui	Short Term Contingent Consideration Gross ShortTermContingentConsiderationGross	1000000	usd
CY2023Q4	icui	Long Term Contingent Consideration Gross LongTermContingentConsiderationGross	1500000	usd
CY2023Q4	icui	Ownership Requirement For Earnout Payment OwnershipRequirementForEarnoutPayment	0.500
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	26300000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	2589000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2589000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	55158000	usd
CY2022	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-32091000	usd
CY2022	icui	Currency Translation On Earn Out CurrencyTranslationOnEarnOut	84000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	25572000	usd
CY2023	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-16247000	usd
CY2023	icui	Fair Value Measurements With Unobservable Inputs Reconciliation Other FairValueMeasurementsWithUnobservableInputsReconciliationOther	-496000	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	3379000	usd
CY2023	icui	Currency Translation On Earn Out CurrencyTranslationOnEarnOut	-41000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5491000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	35900000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	11700000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	64878000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	27586000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	17833000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	21635000	usd
CY2023Q4	icui	Prepaid Vendor Expenses PrepaidVendorExpenses	1309000	usd
CY2022Q4	icui	Prepaid Vendor Expenses PrepaidVendorExpenses	3052000	usd
CY2023Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	1668000	usd
CY2022Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	2395000	usd
CY2023Q4	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	9547000	usd
CY2022Q4	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	16322000	usd
CY2023Q4	icui	Prepaidothertaxes Prepaidothertaxes	2748000	usd
CY2022Q4	icui	Prepaidothertaxes Prepaidothertaxes	3546000	usd
CY2023Q4	icui	Deferredtaxcharge Deferredtaxcharge	5822000	usd
CY2022Q4	icui	Deferredtaxcharge Deferredtaxcharge	3830000	usd
CY2023Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	6785000	usd
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	4860000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	1196000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	1329000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3667000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3532000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73640000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	88932000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	30627000	usd
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	27086000	usd
CY2023Q4	icui	Spare Parts SpareParts	46496000	usd
CY2022Q4	icui	Spare Parts SpareParts	38498000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3120000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3178000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	3439000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	5156000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2707000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2598000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2755000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2193000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	94020000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	105462000	usd
CY2023Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	52250000	usd
CY2022Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	44304000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	37992000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	30254000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20161000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18169000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	2803000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	5317000	usd
CY2023Q4	icui	Accrued Product Field Action. AccruedProductFieldAction.	30281000	usd
CY2022Q4	icui	Accrued Product Field Action. AccruedProductFieldAction.	24517000	usd
CY2023Q4	icui	Accrued Liability Italy Payment Scheme AccruedLiabilityItalyPaymentScheme	23176000	usd
CY2022Q4	icui	Accrued Liability Italy Payment Scheme AccruedLiabilityItalyPaymentScheme	7900000	usd
CY2023Q4	icui	Accruedlegalfees Accruedlegalfees	1874000	usd
CY2022Q4	icui	Accruedlegalfees Accruedlegalfees	3137000	usd
CY2023Q4	icui	Accruedsalestaxes Accruedsalestaxes	6748000	usd
CY2022Q4	icui	Accruedsalestaxes Accruedsalestaxes	5844000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3682000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3097000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	31640000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	30838000	usd
CY2023Q4	icui	Accruedothertaxes Accruedothertaxes	3024000	usd
CY2022Q4	icui	Accruedothertaxes Accruedothertaxes	5794000	usd
CY2023Q4	icui	Outsidesalescommissions Outsidesalescommissions	13049000	usd
CY2022Q4	icui	Outsidesalescommissions Outsidesalescommissions	17063000	usd
CY2023Q4	icui	Accruedfreight Accruedfreight	17215000	usd
CY2022Q4	icui	Accruedfreight Accruedfreight	17988000	usd
CY2023Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	3568000	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	5923000	usd
CY2023Q4	icui	Accrued Audit Fees AccruedAuditFees	5492000	usd
CY2022Q4	icui	Accrued Audit Fees AccruedAuditFees	6279000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	2575000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	2928000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1431000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1033000	usd
CY2023Q4	icui	Accrued Research And Development Liability AccruedResearchAndDevelopmentLiability	0	usd
CY2022Q4	icui	Accrued Research And Development Liability AccruedResearchAndDevelopmentLiability	3538000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8664000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6999000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	268215000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	242769000	usd
CY2022Q4	icui	Contra Ar Italy Payment Scheme ContraARItalyPaymentScheme	12100000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	52972000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	60916000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1954000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1855000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10585000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	16239000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	4207000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	5314000	usd
CY2023Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	841000	usd
CY2022Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	997000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	3882000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	3489000	usd
CY2023Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	100497000	usd
CY2022Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	114104000	usd
CY2023Q4	icui	Total Senior Secured Credit Facility TotalSeniorSecuredCreditFacility	2200000000	usd
CY2023Q4	icui	Revolver Sub Limits RevolverSubLimits	50000000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	37800000	usd
CY2023Q4	icui	Interest Percentage Added To Federal Funds Rate InterestPercentageAddedToFederalFundsRate	0.0050
CY2023Q4	icui	Interest Percentage Added To Base Rate InterestPercentageAddedToBaseRate	0.0100
CY2023Q4	icui	Ter Sofr Interest Rate Adjustment For Base Rate Loans TerSOFRInterestRateAdjustmentForBaseRateLoans	0.0010
CY2023	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025
CY2023Q4	icui	Term A Principal Payment First2 Years TermAPrincipalPaymentFirst2Years	0.0250
CY2023Q4	icui	Term A Principal Payment Year3 And4 TermAPrincipalPaymentYear3And4	0.0500
CY2023Q4	icui	Term A Principal Payment In Year5 TermAPrincipalPaymentInYear5	0.0750
CY2023Q4	icui	Term Loan B Principal Payment TermLoanBPrincipalPayment	0.0025
CY2022Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	16000000	usd
CY2022	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	22400000	usd
CY2023	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	29700000	usd
CY2023Q4	icui	Leverage Ratio Calculation Ceiling Subtracted Amount LeverageRatioCalculationCeilingSubtractedAmount	500000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	150000000	usd
CY2023	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2022-11-08
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	0	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-19168000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1628770000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	51000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1577770000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	51000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	51000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	72250000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	672563000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	8500000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	792625000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1647938000	usd
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	125550000	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	66770000	usd
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	0	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6814000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6972000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	240000	usd
CY2023	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	1518000	usd
CY2022	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	1290000	usd
CY2021	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	221000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	133882000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	75032000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	461000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-136980000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-135646000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	81484000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	58681000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	21237000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	41702000	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-78299000	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-114409000	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	123186000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-8235000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4128000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	20646000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5035000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3799000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3444000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	26035000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	12924000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	7236000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	22835000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20851000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	31326000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-43042000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-42012000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-8154000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-14657000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-11239000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1815000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-13780000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-7723000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1306000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-71479000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-60974000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11275000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-48644000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-40123000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20051000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	24500000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-16443000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-24026000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	25869000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-6057000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.077
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-5050000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.044
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2907000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.024
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	9824000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.125
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	3636000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.032
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	2443000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.020
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	2658000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Gilti Percent EffectiveIncomeTaxRateReconciliationGiltiPercent	0.034
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	2303000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Gilti Percent EffectiveIncomeTaxRateReconciliationGiltiPercent	0.020
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Gilti Amount EffectiveIncomeTaxRateReconciliationGiltiAmount	711000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Gilti Percent EffectiveIncomeTaxRateReconciliationGiltiPercent	0.006
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2506000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.032
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2943000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.025
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2983000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.024
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-289000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.004
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-3721000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.032
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-4263000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.035
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	3299000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.042
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	2269000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.020
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	3775000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Fdii Percent EffectiveIncomeTaxRateReconciliationFdiiPercent	0.031
CY2023	icui	Effective Income Tax Rate Reconciliation Transaction Cost EffectiveIncomeTaxRateReconciliationTransactionCost	0	usd
CY2023	icui	Effective Tax Rate Reconcilation Transaction Cost Percent EffectiveTaxRateReconcilationTransactionCostPercent	0
CY2022	icui	Effective Income Tax Rate Reconciliation Transaction Cost EffectiveIncomeTaxRateReconciliationTransactionCost	2299000	usd
CY2022	icui	Effective Tax Rate Reconcilation Transaction Cost Percent EffectiveTaxRateReconcilationTransactionCostPercent	-0.020
CY2021	icui	Effective Income Tax Rate Reconciliation Transaction Cost EffectiveIncomeTaxRateReconciliationTransactionCost	0	usd
CY2021	icui	Effective Tax Rate Reconcilation Transaction Cost Percent EffectiveTaxRateReconcilationTransactionCostPercent	0
CY2023	icui	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	-3407000	usd
CY2023	icui	Effective Income Tax Rate Reconciliation Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent	0.044
CY2022	icui	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	6830000	usd
CY2022	icui	Effective Income Tax Rate Reconciliation Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent	0.060
CY2021	icui	Effective Income Tax Rate Reconciliation Contingent Consideration EffectiveIncomeTaxRateReconciliationContingentConsideration	29000	usd
CY2021	icui	Effective Income Tax Rate Reconciliation Contingent Consideration Percent EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent	0
CY2023	icui	Effectiveincometaxreconciliationnondeductiblecompensation Effectiveincometaxreconciliationnondeductiblecompensation	3268000	usd
CY2023	icui	Effectivetaxratereconciliationnondeductiblecomppercent Effectivetaxratereconciliationnondeductiblecomppercent	-0.042
CY2022	icui	Effectiveincometaxreconciliationnondeductiblecompensation Effectiveincometaxreconciliationnondeductiblecompensation	3942000	usd
CY2022	icui	Effectivetaxratereconciliationnondeductiblecomppercent Effectivetaxratereconciliationnondeductiblecomppercent	-0.034
CY2021	icui	Effectiveincometaxreconciliationnondeductiblecompensation Effectiveincometaxreconciliationnondeductiblecompensation	1812000	usd
CY2021	icui	Effectivetaxratereconciliationnondeductiblecomppercent Effectivetaxratereconciliationnondeductiblecomppercent	0.015
CY2023	icui	Effective Income Tax Rate Reconciliation Tax Reserve Releases EffectiveIncomeTaxRateReconciliationTaxReserveReleases	-6884000	usd
CY2023	icui	Effective Income Tax Rate Reconciliation Tax Reserve Releases Percent EffectiveIncomeTaxRateReconciliationTaxReserveReleasesPercent	0.088
CY2022	icui	Effective Income Tax Rate Reconciliation Tax Reserve Releases EffectiveIncomeTaxRateReconciliationTaxReserveReleases	-1834000	usd
CY2022	icui	Effective Income Tax Rate Reconciliation Tax Reserve Releases Percent EffectiveIncomeTaxRateReconciliationTaxReserveReleasesPercent	0.016
CY2021	icui	Effective Income Tax Rate Reconciliation Tax Reserve Releases EffectiveIncomeTaxRateReconciliationTaxReserveReleases	0	usd
CY2021	icui	Effective Income Tax Rate Reconciliation Tax Reserve Releases Percent EffectiveIncomeTaxRateReconciliationTaxReserveReleasesPercent	0
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-545000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1642000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.014
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2245000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.018
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-48644000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.621
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-40123000	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.351
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20051000	usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.163
CY2023Q4	icui	Noncurrentdeferredtaxasset Noncurrentdeferredtaxasset	201934000	usd
CY2022Q4	icui	Noncurrentdeferredtaxasset Noncurrentdeferredtaxasset	143119000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	18590000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	94552000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	9000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9500000	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	20400000	usd
CY2023	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	8000000	usd
CY2023	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.33
CY2022	us-gaap	Income Tax Holiday Aggregate Dollar Amount IncomeTaxHolidayAggregateDollarAmount	8100000	usd
CY2022	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.34
CY2023Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	246800000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	78600000	usd
CY2023	icui	Unrecognizedtaxbenefitspotentialdecreasefromlapseofstatuteoflimitations Unrecognizedtaxbenefitspotentialdecreasefromlapseofstatuteoflimitations	6700000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	1400000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	200000	usd
CY2023Q4	icui	Incometaxexaminationincreasedecreaseininterestliabilitiesfromprioryear Incometaxexaminationincreasedecreaseininterestliabilitiesfromprioryear	700000	usd
CY2023Q4	icui	Incometaxexaminationincreasedecreaseinpenaltiesliabilityfrom Prior Year IncometaxexaminationincreasedecreaseinpenaltiesliabilityfromPriorYear	600000	usd
CY2023Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	2900000	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	2000000	usd
CY2022Q4	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	2200000	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties Accrued IncomeTaxExaminationPenaltiesAccrued	2300000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	54053000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21537000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18443000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2347000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	148000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	231000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	29606000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	34607000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4706000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3242000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2455000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	222000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	9591000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1722000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	31000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	403000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	348000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	78558000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	54053000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21537000	usd
CY2023	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	20300000	usd
CY2023Q4	icui	Short Term Contingent Consideration Gross ShortTermContingentConsiderationGross	1000000	usd
CY2023Q4	icui	Long Term Contingent Consideration Gross LongTermContingentConsiderationGross	1500000	usd
CY2023	icui	Contingent Consideration Gross Lt ContingentConsiderationGrossLT	1500000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1236797000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1162557000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	100000000	usd
CY2023	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	59377	shares
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9400000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2428	shares
CY2022	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	47664	shares
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10900000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1633	shares
CY2021	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	40350	shares
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8300000	usd
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	119	shares
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1522000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-15129000	usd
CY2021	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-2618000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-17747000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19269000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-47763000	usd
CY2022	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-13946000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-61709000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-80978000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	58888000	usd
CY2023	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-30991000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	27897000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-53081000	usd
CY2022	us-gaap	Product Liability Accrual Period Expense ProductLiabilityAccrualPeriodExpense	5300000	usd
CY2023Q4	us-gaap	Product Liability Accrual Component Amount ProductLiabilityAccrualComponentAmount	56300000	usd
CY2023Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	29600000	usd
CY2023Q4	icui	Accounts Receivable Purchase Program AccountsReceivablePurchaseProgram	150000000	usd
CY2023	us-gaap	Accounts Receivable Sale AccountsReceivableSale	629100000	usd
CY2023	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	625300000	usd
CY2023	us-gaap	Gain Loss On Sale Of Accounts Receivable GainLossOnSaleOfAccountsReceivable	3700000	usd
CY2023	icui	Cash Remitted To Purchaser CashRemittedToPurchaser	553200000	usd
CY2023Q4	us-gaap	Transfer Of Financial Assets Accounted For As Sales Cash Proceeds Received For Assets Derecognized Amount TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount	75900000	usd
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2020Q4	icui	Warranty And Return Reserve Inventory WarrantyAndReturnReserveInventory	-1613000	usd
CY2021	icui	Warranty And Return Reserve Costs WarrantyAndReturnReserveCosts	263000	usd
CY2021	icui	Warranty And Return Reserve Inventory Charged To Other Accounts WarrantyAndReturnReserveInventoryChargedToOtherAccounts	533000	usd
CY2021	icui	Warranty And Return Reserve Inventory Write Offs WarrantyAndReturnReserveInventoryWriteOffs	0	usd
CY2021Q4	icui	Warranty And Return Reserve Inventory WarrantyAndReturnReserveInventory	-1883000	usd
CY2021Q4	icui	Warranty And Return Reserve Inventory WarrantyAndReturnReserveInventory	-1883000	usd
CY2022	icui	Warranty And Return Reserve Costs WarrantyAndReturnReserveCosts	5266000	usd
CY2022	icui	Warranty And Return Reserve Inventory Charged To Other Accounts WarrantyAndReturnReserveInventoryChargedToOtherAccounts	-47436000	usd
CY2022	icui	Warranty And Return Reserve Inventory Write Offs WarrantyAndReturnReserveInventoryWriteOffs	0	usd
CY2022Q4	icui	Warranty And Return Reserve Inventory WarrantyAndReturnReserveInventory	50819000	usd
CY2022Q4	icui	Warranty And Return Reserve Inventory WarrantyAndReturnReserveInventory	50819000	usd
CY2023	icui	Warranty And Return Reserve Costs WarrantyAndReturnReserveCosts	20290000	usd
CY2023	icui	Warranty And Return Reserve Inventory Charged To Other Accounts WarrantyAndReturnReserveInventoryChargedToOtherAccounts	13313000	usd
CY2023	icui	Warranty And Return Reserve Inventory Write Offs WarrantyAndReturnReserveInventoryWriteOffs	0	usd
CY2023Q4	icui	Warranty And Return Reserve Inventory WarrantyAndReturnReserveInventory	57796000	usd

Files In Submission

Name	View Source	Status
0000883984-24-000005-index-headers.html	Edgar Link	pending
0000883984-24-000005-index.html	Edgar Link	pending
0000883984-24-000005.txt	Edgar Link	pending
0000883984-24-000005-xbrl.zip	Edgar Link	pending
exhibit103executiveofficer.htm	Edgar Link	pending
exhibit104non-employeedire.htm	Edgar Link	pending
exhibit21subsidiariesofreg.htm	Edgar Link	pending
exhibit231consentofdeloitt.htm	Edgar Link	pending
exhibit311123123.htm	Edgar Link	pending
exhibit312123123.htm	Edgar Link	pending
exhibit32123123.htm	Edgar Link	pending
exhibit971clawbackpolicy.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
icui-20231231.htm	Edgar Link	pending
icui-20231231.xsd	Edgar Link	pending
icui-20231231_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
icui-20231231_cal.xml	Edgar Link	unprocessable
icui-20231231_def.xml	Edgar Link	unprocessable
icui-20231231_lab.xml	Edgar Link	unprocessable
icui-20231231_pre.xml	Edgar Link	unprocessable
icui-20231231_htm.xml	Edgar Link	completed
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICUI
ICU MEDICAL INC/DE Stock $icui

2024 Q1 Form 10-K Financial Statement

#000088398424000005 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI ICU MEDICAL INC/DE Stock $icui

2024 Q1 Form 10-K Financial Statement

#000088398424000005 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI
ICU MEDICAL INC/DE Stock $icui